10-K · June 29, 2026
MiniMed Group, Inc. (MMED) reported strong revenue growth of 14% YoY, reaching $3.1 billion. Although operating losses persist, improvements in gross profit margins were observed, primarily driven by increased sales of…
Earnings analysis · 10-Q
MMED earnings analysis
Filed September 8, 2026 · Our reading of the company's report
The latest report
The extracted 10-Q text does not include the financial statements or MD&A needed to assess quarterly revenue, margins, EPS, segment trends, balance-sheet changes, or cash flow. The principal quantified exposure…
Read full summary
The extracted 10-Q text does not include the financial statements or MD&A needed to assess quarterly revenue, margins, EPS, segment trends, balance-sheet changes, or cash flow. The principal quantified exposure disclosed is foreign currency: approximately $499 million of forward-contract notional as of July 31, 2026, with an estimated $50 million fair-value sensitivity to a uniform 10% currency move. Management reported effective disclosure controls and no material changes to the company’s 2026 Form 10-K risk factors.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Currency exposure partially hedged
The company had approximately $499 million of outstanding foreign-currency forward contracts as of July 31, 2026, providing economic hedging for certain currency exposures.
-
Disclosure controls remained effective
Management reported that its disclosure controls were effective as of the end of the period, and stated that there had been no changes during the quarter that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
-
Hedge offsets underlying FX exposure
The filing states that a uniform 10% move in the U.S. dollar would change the fair value of the outstanding currency contracts by approximately $50 million, with gains and losses generally offset by the underlying exposures.
What to watch
-
Material foreign-exchange exposure
The company remains exposed to foreign-exchange movements affecting earnings, cash flows, assets, and liabilities. The $499 million notional hedge portfolio would experience an estimated $50 million fair-value change under a uniform 10% currency move, before considering offsets from the underlying exposures.
-
No new risk-factor disclosures
The filing states that there were no material changes to the risk factors presented in the 2026 Form 10-K; therefore, the report does not identify a newly added or escalated risk factor versus the prior annual filing.
Management's outlook
No quantitative revenue or EPS outlook was provided in the extracted 10-Q text; prior outlook information appeared in the 8-K and earnings materials.
Earlier filings 2
10-Q · April 17, 2026
MiniMed Group reported quarter revenue growth to $790.0M (up $103.0M or ~15% y/y) but posted a $111.0M net loss for the quarter, driven by a $118.0M contract termination/asset write‑off charge and elevated restructuring…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.